Praised for its ‘depth and experience’, Hogan Lovells is well-equipped to advise clients in the pharmaceutical, medical device and healthcare industries, with expertise across transactional, regulatory, patent litigation and product liability matters. The firm handles collaborations, M&A and licensing transactions, and is also well-placed to advise on regulatory frameworks, compliance and agency investigations, with a particular focus on emerging technologies. The practice is also experienced in multijurisdictional patent and product liability litigation and IP lifecycle management, supported by its in-house scientific unit. The team is co-chaired by ’highly regarded’ patent litigator Stephen Bennett and regulatory specialist Jane Summerfield, who brings ’eminent’ regulatory knowledge and a commercial approach to clinical trials, marketing authorisations, and manufacturing licenses. Praised for his ‘innovative litigation strategy’, fellow co-lead Matthew Felwick leverages his scientific background in product liability and commercial disputes. Penny Powell focuses on complex commercial transactions, while Daniel Brook and Stella Wong handle patent disputes across jurisdictions.
Legal 500 Editorial commentary
Phone
+44 20 7296 2000
Email
Profile

Profile

Work Department
Life Sciences
Position

Partner

Career

Jane Summerfield is Co-Head of our Life Sciences & Health Care industry sector and leads the Hogan Lovells life sciences regulatory and commercial practice in London. She advises life sciences companies on a wide range of regulatory matters, including clinical trial requirements, early access schemes, marketing authorisations, manufacturing and distribution licenses, CE marking, product labelling, advertising and marketing activities, non-promotional activities, and pricing and reimbursement.

Jane also advises on commercial contractual arrangements, including consultancy, sponsorship, co-promotion, collaboration, manufacturing, distribution, services, quality, and pharmacovigilance agreements.

Jane works with clients to resolve issues with UK enforcement authorities and regulatory bodies, including the Medicines and Healthcare products Regulatory Agency (MHRA), Prescription Medicines Code of Practice Authority (PMCPA), Advertising Standards Authority (ASA), and Trading Standards.

Jane combines a scientific background with deep regulatory knowledge and a commercial approach, providing "clear responses with business impact" Chambers UK.

Languages
English
Education

MA Biological Sciences, University of Oxford, New College

PgDL and LPC, BPP University Law School

Content supplied by Hogan Lovells

Testimonials

Collated independently by Legal 500 research team.

  • ‘The strongest all-round patent department in London. Ably assisted by the offices around Europe doing UPC work.’

    'The Hogan Lovells life sciences team in London is the undoubted market leader. A global strength for the firm, the London office in particular stands out for its depth and experience in the field. From global regulatory advice on bringing new life science products to the market to dealing with any liabilities arising, the team is outstanding in all respects.'

    'Absolutely excellent client care from an exceptionally personable and knowledgeable team. They know their clients' businesses inside out and understand their commercial objectives.'

    'As well as UK life sciences advice, we tend to need the same answers for multiple European and other jurisdictions. We find that HL has the best 'one-stop shop' if we need a single firm to manage multi-jurisdictional advice in this space. We are further aware of HL developing AI tools that are helping to advance their services. Also commendable is their willingness to come and deliver training to our teams.'

    'Matthew Felwick is a real specialist in the area with long experience of life science disputes. He is on top of the technical and expert issues, while providing commercially focused advice and innovative litigation strategy. Lara Knight is a rising star in the field who masters detail without becoming bogged down in it. Lucy Ward is highly skilled and experienced in public inquiry work related to life science products.'

    ‘Stephen Bennett is very highly regarded by all his peers. Daniel Brook is very careful and competent. Katie McConnell is also excellent. Highly rated associates include Imogen Ireland, Ian Moss and Helen Poulson and Raina Hayles.’

    'Elise Martin is a pleasure to work with. She is an excellent communicator and works collaboratively with counsel - a real team player. She and I worked together on a product liability case involving tight deadlines, and she was calm, professional, and upbeat throughout (including taking calls on a bank holiday weekend).'

    'Jane Summerfield is eminently knowledgeable, highly responsive, and cares deeply about delivering the right commercial solution for her clients.'

Key clients

  • Recordati Industria Chimica E Farmaceutica SPA Eli Lilly Merck Sharp and Dohme (MSD) Astellas Pharmaceuticals Novartis AG Aztiq Molecular Partners Zimmer Biomet Viatris Akebia Therapeutics

Work highlights

Advised Recordati on the acquisition of global rights to Enjaymo® (sutimlimab) from Sanofi, with a potential matter value of US$1.075 billion.
Representing Lilly in an ongoing multi-jurisdictional dispute concerning their cancer drug, pemetrexed.
Advising Zimmer Biomet and its European subsidiaries regarding a voluntary recall of their NexGen Stemmed Option Tibial prosthetic knee component and coordinating the defence of personal injury claims across European jurisdictions.